Jackson Heart Study: Aggregate cardiovascular disease risk and auditory profiles
- PMID: 37090882
- PMCID: PMC10116973
- DOI: 10.1002/lio2.1031
Jackson Heart Study: Aggregate cardiovascular disease risk and auditory profiles
Abstract
Objectives: Evaluate the relationship between cardiovascular disease (CVD) risk factors and cochlear function in African Americans.
Methods: Relationships between hearing loss, cochlear function, and CVD risk factors were assessed in a cross-sectional analysis of 1106 Jackson Heart Study participants. Hearing loss was defined as puretone average (PTA0.5,1,2,4) > 15 dB HL. Distortion product otoacoustic emissions (DPOAEs) were collected for f 2 = 1.0-8.0 kHz. Two amplitude averages were computed: DPOAElow (f 2 ≤ 4 kHz) and DPOAEhigh (f 2 ≥ 6 kHz). Based on major CVD risk factors (diabetes, current smoking, total cholesterol ≥240 mg/dL or treatment, and systolic blood pressure [BP]/diastolic BP ≥ 140/≥90 mmHg or treatment), four risk groups were created: 0, 1, 2, and ≥3 risk factors. Logistic regression estimated the odds of hearing loss and absent/reduced DPOAElow and DPOAEhigh by CVD risk status adjusting for age, sex, education, BMI, vertigo, and noise exposure.
Results: With multivariable adjustment, diabetes was associated with hearing loss (OR = 1.48 [95% CI: 1.04-2.10]). However, there was not a statistically significant relationship between CVD risk factors (individually or for overall risk) and DPOAEs.
Conclusion: Diabetes was associated with hearing loss. Neither individual CVD risk factors nor overall risk showed a relationship to cochlear dysfunction.
Level of evidence: 2b.
Keywords: Jackson Heart Study; audiology; cardiovascular disease risk factors; distortion product otoacoustic emissions; hearing loss; otology; sensorineural hearing loss.
© 2023 The Authors. Laryngoscope Investigative Otolaryngology published by Wiley Periodicals LLC on behalf of The Triological Society.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Association Between Nonoptimal Blood Pressure and Cochlear Function.Ear Hear. 2021 Mar/Apr;42(2):393-404. doi: 10.1097/AUD.0000000000000937. Ear Hear. 2021. PMID: 32826511
-
Hearing Loss and Cardiovascular Disease Risk Profiles: Data from the Hispanic Community Health Study/Study of Latinos.J Am Acad Audiol. 2022 Oct;33(9-10):445-459. doi: 10.1055/s-0042-1758529. Epub 2024 Sep 13. J Am Acad Audiol. 2022. PMID: 39271108
-
Recovery From Idiopathic Sudden Sensorineural Hearing Loss: Association With Cardiovascular Disease Risk.Am J Audiol. 2023 Dec 4;32(4):865-877. doi: 10.1044/2023_AJA-22-00135. Epub 2023 Sep 25. Am J Audiol. 2023. PMID: 37748022
-
Relationship of cardiovascular disease risk and hearing loss in a clinical population.Sci Rep. 2023 Jan 30;13(1):1642. doi: 10.1038/s41598-023-28599-9. Sci Rep. 2023. PMID: 36717643 Free PMC article.
-
Distortion-product otoacoustic emissions and cochlear microphonics: relationships in patients with and without endolymphatic hydrops.Laryngoscope. 2001 Jun;111(6):946-54. doi: 10.1097/00005537-200106000-00004. Laryngoscope. 2001. PMID: 11404602
References
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous